Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.959 | 7.22e-17 | 1.01e-04 | 1.12e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
FTSJ1 | 24140 | 4 | -2.463 | 2.994 | 95 | Yes | Yes |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
GSPT1 | 2935 | 1 | -2.313 | 2.959 | 30 | Yes | Yes |
ETF1 | 2107 | 3 | -2.829 | 2.959 | 71 | Yes | Yes |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
YY1 | 7528 | 24 | -2.572 | 3.120 | 114 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
[ CDKN2A ] | 1029 | 2 | -1.774 | 2.959 | 126 | - | - |
E4F1 | 1877 | 1 | -2.370 | 2.959 | 27 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
NFRKB | 4798 | YY1 | 7528 | pp | -- | int.I2D: BioGrid |
CDKN2A | 1029 | GSPT1 | 2935 | pp | -- | int.I2D: BCI; int.HPRD: in vitro, in vivo, yeast 2-hybrid |
CDKN2A | 1029 | E4F1 | 1877 | pp | -- | int.I2D: BioGrid; int.HPRD: in vivo |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
ETF1 | 2107 | GSPT1 | 2935 | pp | -- | int.I2D: MINT, BCI, BioGrid, HPRD; int.Mint: MI:0915(physical association); int.HPRD: in vivo, yeast 2-hybrid |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
CDKN2A | 1029 | YY1 | 7528 | pp | -- | int.I2D: BioGrid, BIND, BCI |
CDKN2A | 1029 | HNRNPU | 3192 | pp | -- | int.Intact: MI:0915(physical association) |
CDKN2A | 1029 | FTSJ1 | 24140 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0003747 | translation release factor activity | 3.17e-06 | 4.57e-02 | 9.357 | 2 | 2 | 4 |
GO:0044212 | transcription regulatory region DNA binding | 5.50e-06 | 7.93e-02 | 4.964 | 4 | 17 | 168 |
GO:0003714 | transcription corepressor activity | 6.92e-06 | 9.98e-02 | 4.881 | 4 | 11 | 178 |
GO:0003677 | DNA binding | 7.34e-06 | 1.06e-01 | 2.914 | 7 | 49 | 1218 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 4.11e-05 | 5.92e-01 | 7.656 | 2 | 2 | 13 |
GO:0006479 | protein methylation | 4.79e-05 | 6.91e-01 | 7.549 | 2 | 2 | 14 |
GO:0031011 | Ino80 complex | 4.79e-05 | 6.91e-01 | 7.549 | 2 | 6 | 14 |
GO:0005654 | nucleoplasm | 5.85e-05 | 8.43e-01 | 2.862 | 6 | 64 | 1082 |
GO:0006974 | cellular response to DNA damage stimulus | 1.75e-04 | 1.00e+00 | 4.703 | 3 | 7 | 151 |
GO:0003713 | transcription coactivator activity | 6.56e-04 | 1.00e+00 | 4.053 | 3 | 24 | 237 |
GO:0044822 | poly(A) RNA binding | 6.63e-04 | 1.00e+00 | 2.634 | 5 | 50 | 1056 |
GO:0008134 | transcription factor binding | 6.97e-04 | 1.00e+00 | 4.023 | 3 | 18 | 242 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0009794 | regulation of mitotic cell cycle, embryonic | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0005515 | protein binding | 1.10e-03 | 1.00e+00 | 1.122 | 10 | 198 | 6024 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.37e-03 | 1.00e+00 | 2.908 | 4 | 39 | 699 |
GO:0034696 | response to prostaglandin F | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0006403 | RNA localization | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0008175 | tRNA methyltransferase activity | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0055105 | ubiquitin-protein transferase inhibitor activity | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0003723 | RNA binding | 1.89e-03 | 1.00e+00 | 3.524 | 3 | 18 | 342 |
GO:0006415 | translational termination | 1.91e-03 | 1.00e+00 | 4.914 | 2 | 2 | 87 |
GO:0016149 | translation release factor activity, codon specific | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0035985 | senescence-associated heterochromatin focus | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0035986 | senescence-associated heterochromatin focus assembly | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:2000111 | positive regulation of macrophage apoptotic process | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:2000774 | positive regulation of cellular senescence | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.25e-03 | 1.00e+00 | 4.524 | 2 | 4 | 114 |
GO:0001714 | endodermal cell fate specification | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:1902510 | regulation of apoptotic DNA fragmentation | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0006449 | regulation of translational termination | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0034393 | positive regulation of smooth muscle cell apoptotic process | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0007050 | cell cycle arrest | 3.83e-03 | 1.00e+00 | 4.402 | 2 | 5 | 124 |
GO:0010564 | regulation of cell cycle process | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0002181 | cytoplasmic translation | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 3 | 6 |
GO:0035497 | cAMP response element binding | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0006355 | regulation of transcription, DNA-templated | 5.05e-03 | 1.00e+00 | 2.395 | 4 | 43 | 997 |
GO:0046825 | regulation of protein export from nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 2 | 7 |
GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 7 |
GO:0000082 | G1/S transition of mitotic cell cycle | 5.48e-03 | 1.00e+00 | 4.137 | 2 | 3 | 149 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0005634 | nucleus | 6.13e-03 | 1.00e+00 | 1.202 | 8 | 159 | 4559 |
GO:0010225 | response to UV-C | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 2 | 9 |
GO:0006983 | ER overload response | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0048103 | somatic stem cell division | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0000400 | four-way junction DNA binding | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0005667 | transcription factor complex | 7.49e-03 | 1.00e+00 | 3.905 | 2 | 17 | 175 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0071850 | mitotic cell cycle arrest | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 10 |
GO:0090399 | replicative senescence | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 10 |
GO:0033235 | positive regulation of protein sumoylation | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 4 | 11 |
GO:0001953 | negative regulation of cell-matrix adhesion | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 2 | 12 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 2 | 12 |
GO:0035198 | miRNA binding | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0030889 | negative regulation of B cell proliferation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0001824 | blastocyst development | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 15 |
GO:0051276 | chromosome organization | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 16 |
GO:0048593 | camera-type eye morphogenesis | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0010467 | gene expression | 1.24e-02 | 1.00e+00 | 2.556 | 3 | 45 | 669 |
GO:0090398 | cellular senescence | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 18 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 1.44e-02 | 1.00e+00 | 6.109 | 1 | 2 | 19 |
GO:0001227 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 1.44e-02 | 1.00e+00 | 6.109 | 1 | 2 | 19 |
GO:0071158 | positive regulation of cell cycle arrest | 1.44e-02 | 1.00e+00 | 6.109 | 1 | 2 | 19 |
GO:0032757 | positive regulation of interleukin-8 production | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 1 | 20 |
GO:0042326 | negative regulation of phosphorylation | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 21 |
GO:0008637 | apoptotic mitochondrial changes | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 2 | 21 |
GO:0031648 | protein destabilization | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 21 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 1 | 23 |
GO:0051059 | NF-kappaB binding | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 3 | 25 |
GO:0031519 | PcG protein complex | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 1 | 25 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.93e-02 | 1.00e+00 | 2.318 | 3 | 41 | 789 |
GO:0035329 | hippo signaling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 1 | 26 |
GO:0043022 | ribosome binding | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 27 |
GO:0034644 | cellular response to UV | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 1 | 30 |
GO:0031647 | regulation of protein stability | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 4 | 30 |
GO:0070534 | protein K63-linked ubiquitination | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 1 | 31 |
GO:0016604 | nuclear body | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 3 | 31 |
GO:0042594 | response to starvation | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 32 |
GO:0008283 | cell proliferation | 2.48e-02 | 1.00e+00 | 2.999 | 2 | 14 | 328 |
GO:0043565 | sequence-specific DNA binding | 2.74e-02 | 1.00e+00 | 2.922 | 2 | 11 | 346 |
GO:0005829 | cytosol | 2.85e-02 | 1.00e+00 | 1.393 | 5 | 86 | 2496 |
GO:0035019 | somatic stem cell maintenance | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 4 | 46 |
GO:0006986 | response to unfolded protein | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 4 | 50 |
GO:0040008 | regulation of growth | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 2 | 50 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.79e-02 | 1.00e+00 | 2.667 | 2 | 24 | 413 |
GO:0034976 | response to endoplasmic reticulum stress | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 51 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.89e-02 | 1.00e+00 | 2.646 | 2 | 30 | 419 |
GO:0009611 | response to wounding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 5 | 52 |
GO:0000724 | double-strand break repair via homologous recombination | 4.12e-02 | 1.00e+00 | 4.575 | 1 | 2 | 55 |
GO:0002039 | p53 binding | 4.12e-02 | 1.00e+00 | 4.575 | 1 | 4 | 55 |
GO:0005737 | cytoplasm | 4.20e-02 | 1.00e+00 | 1.062 | 6 | 124 | 3767 |
GO:0006396 | RNA processing | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 6 | 59 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 2 | 61 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 4.70e-02 | 1.00e+00 | 4.379 | 1 | 3 | 63 |
GO:0006310 | DNA recombination | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 7 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 4 | 65 |
GO:0044267 | cellular protein metabolic process | 4.87e-02 | 1.00e+00 | 2.468 | 2 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.95e-02 | 1.00e+00 | 2.456 | 2 | 24 | 478 |
GO:0010468 | regulation of gene expression | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 2 | 68 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 5.29e-02 | 1.00e+00 | 4.207 | 1 | 4 | 71 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 74 |
GO:0002020 | protease binding | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 6 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 1 | 75 |
GO:0007265 | Ras protein signal transduction | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 3 | 75 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 5.72e-02 | 1.00e+00 | 4.090 | 1 | 3 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 7 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 5.86e-02 | 1.00e+00 | 4.053 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 6.15e-02 | 1.00e+00 | 3.982 | 1 | 2 | 83 |
GO:0009952 | anterior/posterior pattern specification | 6.15e-02 | 1.00e+00 | 3.982 | 1 | 4 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 6.37e-02 | 1.00e+00 | 3.930 | 1 | 8 | 86 |
GO:0050821 | protein stabilization | 6.51e-02 | 1.00e+00 | 3.897 | 1 | 3 | 88 |
GO:0016363 | nuclear matrix | 6.73e-02 | 1.00e+00 | 3.849 | 1 | 6 | 91 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.77e-02 | 1.00e+00 | 2.202 | 2 | 37 | 570 |
GO:0001649 | osteoblast differentiation | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 5 | 92 |
GO:0005770 | late endosome | 6.87e-02 | 1.00e+00 | 3.817 | 1 | 2 | 93 |
GO:0006364 | rRNA processing | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 3 | 94 |
GO:0030308 | negative regulation of cell growth | 8.08e-02 | 1.00e+00 | 3.575 | 1 | 6 | 110 |
GO:0030529 | ribonucleoprotein complex | 8.22e-02 | 1.00e+00 | 3.549 | 1 | 5 | 112 |
GO:0005819 | spindle | 8.22e-02 | 1.00e+00 | 3.549 | 1 | 1 | 112 |
GO:0000209 | protein polyubiquitination | 8.50e-02 | 1.00e+00 | 3.499 | 1 | 3 | 116 |
GO:0006260 | DNA replication | 8.85e-02 | 1.00e+00 | 3.438 | 1 | 3 | 121 |
GO:0006351 | transcription, DNA-templated | 9.00e-02 | 1.00e+00 | 1.444 | 3 | 57 | 1446 |
GO:0016055 | Wnt signaling pathway | 1.00e-01 | 1.00e+00 | 3.248 | 1 | 4 | 138 |
GO:0000398 | mRNA splicing, via spliceosome | 1.18e-01 | 1.00e+00 | 2.999 | 1 | 15 | 164 |
GO:0005730 | nucleolus | 1.21e-01 | 1.00e+00 | 1.261 | 3 | 66 | 1641 |
GO:0031625 | ubiquitin protein ligase binding | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.32e-01 | 1.00e+00 | 2.833 | 1 | 22 | 184 |
GO:0003924 | GTPase activity | 1.40e-01 | 1.00e+00 | 2.735 | 1 | 7 | 197 |
GO:0005622 | intracellular | 1.47e-01 | 1.00e+00 | 2.663 | 1 | 6 | 207 |
GO:0006184 | GTP catabolic process | 1.52e-01 | 1.00e+00 | 2.615 | 1 | 7 | 214 |
GO:0016874 | ligase activity | 1.52e-01 | 1.00e+00 | 2.615 | 1 | 4 | 214 |
GO:0016071 | mRNA metabolic process | 1.58e-01 | 1.00e+00 | 2.556 | 1 | 8 | 223 |
GO:0007067 | mitotic nuclear division | 1.60e-01 | 1.00e+00 | 2.530 | 1 | 6 | 227 |
GO:0008380 | RNA splicing | 1.61e-01 | 1.00e+00 | 2.524 | 1 | 22 | 228 |
GO:0006412 | translation | 1.62e-01 | 1.00e+00 | 2.511 | 1 | 8 | 230 |
GO:0016070 | RNA metabolic process | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 8 | 247 |
GO:0006281 | DNA repair | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 14 | 261 |
GO:0007283 | spermatogenesis | 1.83e-01 | 1.00e+00 | 2.323 | 1 | 3 | 262 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.84e-01 | 1.00e+00 | 2.312 | 1 | 23 | 264 |
GO:0006954 | inflammatory response | 1.92e-01 | 1.00e+00 | 2.243 | 1 | 6 | 277 |
GO:0043234 | protein complex | 2.03e-01 | 1.00e+00 | 2.152 | 1 | 11 | 295 |
GO:0016567 | protein ubiquitination | 2.03e-01 | 1.00e+00 | 2.152 | 1 | 4 | 295 |
GO:0030154 | cell differentiation | 2.07e-01 | 1.00e+00 | 2.123 | 1 | 5 | 301 |
GO:0005525 | GTP binding | 2.13e-01 | 1.00e+00 | 2.081 | 1 | 12 | 310 |
GO:0019901 | protein kinase binding | 2.17e-01 | 1.00e+00 | 2.048 | 1 | 18 | 317 |
GO:0008285 | negative regulation of cell proliferation | 2.39e-01 | 1.00e+00 | 1.893 | 1 | 10 | 353 |
GO:0046982 | protein heterodimerization activity | 2.55e-01 | 1.00e+00 | 1.787 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 2.61e-01 | 1.00e+00 | 1.746 | 1 | 15 | 391 |
GO:0009986 | cell surface | 2.67e-01 | 1.00e+00 | 1.706 | 1 | 9 | 402 |
GO:0016032 | viral process | 3.40e-01 | 1.00e+00 | 1.296 | 1 | 26 | 534 |
GO:0008270 | zinc ion binding | 5.45e-01 | 1.00e+00 | 0.395 | 1 | 27 | 997 |
GO:0005739 | mitochondrion | 5.46e-01 | 1.00e+00 | 0.394 | 1 | 23 | 998 |
GO:0005524 | ATP binding | 6.46e-01 | 1.00e+00 | 0.015 | 1 | 31 | 1298 |
GO:0046872 | metal ion binding | 6.48e-01 | 1.00e+00 | 0.005 | 1 | 29 | 1307 |
GO:0016020 | membrane | 7.44e-01 | 1.00e+00 | -0.358 | 1 | 46 | 1681 |